Literature DB >> 35213778

Screening and enrollment of underrepresented ethnocultural and educational populations in the Alzheimer's Disease Neuroimaging Initiative (ADNI).

Miriam T Ashford1, Rema Raman2, Garrett Miller2, Michael C Donohue2, Ozioma C Okonkwo3, Monica Rivera Mindt4, Rachel L Nosheny5, Godfrey A Coker2, Ronald C Petersen6, Paul S Aisen2, Michael W Weiner7.   

Abstract

INTRODUCTION: An analysis of the ethnocultural and socioeconomic composition of Alzheimer's Disease Neuroimaging Initiative (ADNI) participants is needed to assess the generalizability of ADNI data to diverse populations.
METHODS: ADNI data collected between October 2004 and November 2020 were used to determine ethnocultural and educational composition of the sample and differences in the following metrics: screening, screen fails, enrollment, biomarkers.
RESULTS: Of 3739 screened individuals, 11% identified as being from ethnoculturally underrepresented populations (e.g., Black, Latinx) and 16% had <12 years of education. Of 2286 enrolled participants, 11% identified as ethnoculturally underrepresented individuals and 15% had <12 years of education. This participation is considerably lower than US Census data for adults 60+ (ethnoculturally underrepresented populations: 25%; <12 years of education: 4%). Individuals with <12 years of education failed screening at a higher rate. DISCUSSION: Our findings suggest that ADNI results may not be entirely generalizable to ethnoculturally diverse and low education populations.
© 2022 the Alzheimer's Association.

Entities:  

Keywords:  Alzheimer's Disease Neuroimaging Initiative; Alzheimer's disease; biomarkers; diversity; educational attainment; enrollment; ethnicity; race; screening

Year:  2022        PMID: 35213778      PMCID: PMC9402812          DOI: 10.1002/alz.12640

Source DB:  PubMed          Journal:  Alzheimers Dement        ISSN: 1552-5260            Impact factor:   16.655


  39 in total

Review 1.  A systematic review of barriers and facilitators to minority research participation among African Americans, Latinos, Asian Americans, and Pacific Islanders.

Authors:  Sheba George; Nelida Duran; Keith Norris
Journal:  Am J Public Health       Date:  2013-12-12       Impact factor: 9.308

2.  Retention of Alzheimer Disease Research Participants.

Authors:  Joshua D Grill; Jimmy Kwon; Merilee A Teylan; Aimee Pierce; Eric D Vidoni; Jeffrey M Burns; Allison Lindauer; Joseph Quinn; Jeff Kaye; Daniel L Gillen; Bin Nan
Journal:  Alzheimer Dis Assoc Disord       Date:  2019 Oct-Dec       Impact factor: 2.703

3.  Challenging Assumptions About African American Participation in Alzheimer Disease Trials.

Authors:  Richard E Kennedy; Gary R Cutter; Guoqiao Wang; Lon S Schneider
Journal:  Am J Geriatr Psychiatry       Date:  2017-04-25       Impact factor: 4.105

4.  Recruitment rate to drug trials for dementia of the Alzheimer type.

Authors:  T A Treves; R Verchovsky; S Klimovitsky; A D Korczyn
Journal:  Alzheimer Dis Assoc Disord       Date:  2000 Oct-Dec       Impact factor: 2.703

5.  Prevalence of dementia in three ethnic groups: the South Florida program on aging and health.

Authors:  Jasenka Demirovic; Ronald Prineas; David Loewenstein; Judy Bean; Ranjan Duara; Steven Sevush; Jose Szapocznik
Journal:  Ann Epidemiol       Date:  2003-07       Impact factor: 3.797

6.  Neighborhood deprivation, individual socioeconomic status, and cognitive function in older people: analyses from the English Longitudinal Study of Ageing.

Authors:  Iain A Lang; David J Llewellyn; Kenneth M Langa; Robert B Wallace; Felicia A Huppert; David Melzer
Journal:  J Am Geriatr Soc       Date:  2007-12-24       Impact factor: 5.562

7.  Alzheimer disease in the United States (2010-2050) estimated using the 2010 census.

Authors:  Liesi E Hebert; Jennifer Weuve; Paul A Scherr; Denis A Evans
Journal:  Neurology       Date:  2013-02-06       Impact factor: 9.910

8.  Progress and future challenges in aging and diversity research in the United States.

Authors:  Paul Brewster; Lisa Barnes; Mary Haan; Julene K Johnson; Jennifer J Manly; Anna María Nápoles; Rachel A Whitmer; Luis Carvajal-Carmona; Dawnte Early; Sarah Farias; Elizabeth Rose Mayeda; Rebecca Melrose; Oanh L Meyer; Adina Zeki Al Hazzouri; Ladson Hinton; Dan Mungas
Journal:  Alzheimers Dement       Date:  2018-09-19       Impact factor: 21.566

9.  Representation of ethnic groups in dementia trials: systematic review and meta-analysis.

Authors:  Manav V Vyas; Pranali K Raval; Jennifer A Watt; David F Tang-Wai
Journal:  J Neurol Sci       Date:  2018-09-12       Impact factor: 3.181

10.  Factors Associated with Lumbar Puncture Participation in Alzheimer's Disease Research.

Authors:  Madeleine M Blazel; Karen K Lazar; Carol A Van Hulle; Yue Ma; Aleshia Cole; Alice Spalitta; Nancy Davenport-Sis; Barbara B Bendlin; Michelle Wahoske; Chuck Illingworth; Carey E Gleason; Dorothy F Edwards; Hanna Blazel; Sanjay Asthana; Sterling C Johnson; Cynthia M Carlsson
Journal:  J Alzheimers Dis       Date:  2020       Impact factor: 4.472

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.